Smith Elise, Hunt Matthew, Master Zubin
Institut de Recherche en Santé Publique (IRSPUM), University of Montreal, Montreal, Canada.
BMC Med Ethics. 2014 May 28;15:42. doi: 10.1186/1472-6939-15-42.
Over the past two decades, the promotion of collaborative partnerships involving researchers from low and middle income countries with those from high income countries has been a major development in global health research. Ideally, these partnerships would lead to more equitable collaboration including the sharing of research responsibilities and rewards. While collaborative partnership initiatives have shown promise and attracted growing interest, there has been little scholarly debate regarding the fair distribution of authorship credit within these partnerships.
In this paper, we identify four key authorship issues relevant to global health research and discuss their ethical and practical implications. First, we argue that authorship guidance may not adequately apply to global health research because it requires authors to write or substantially revise the manuscript. Since most journals of international reputation in global health are written in English, this would systematically and unjustly exclude non-English speaking researchers even if they have substantially contributed to the research project. Second, current guidance on authorship order does not address or mitigate unfair practices which can occur in global health research due to power differences between researchers from high and low-middle income countries. It also provides insufficient recognition of "technical tasks" such as local participant recruitment. Third, we consider the potential for real or perceived editorial bias in medical science journals in favour of prominent western researchers, and the risk of promoting misplaced credit and/or prestige authorship. Finally, we explore how diverse cultural practices and expectations regarding authorship may create conflict between researchers from low-middle and high income countries and contribute to unethical authorship practices. To effectively deal with these issues, we suggest: 1) undertaking further empirical and conceptual research regarding authorship in global health research; 2) raising awareness on authorship issues in global health research; and 3) developing specific standards of practice that reflect relevant considerations of authorship in global health research.
Through review of the bioethics and global health literatures, and examination of guidance documents on ethical authorship, we identified a set of issues regarding authorship in collaborative partnerships between researchers from low-middle income countries and high income countries. We propose several recommendations to address these concerns.
在过去二十年中,推动低收入和中等收入国家的研究人员与高收入国家的研究人员建立合作关系,已成为全球卫生研究的一项重大进展。理想情况下,这些合作关系将促成更公平的合作,包括研究责任和回报的共享。虽然合作关系倡议已展现出前景并吸引了越来越多的关注,但对于这些合作关系中作者署名权的公平分配,学术讨论却很少。
在本文中,我们确定了与全球卫生研究相关的四个关键作者署名问题,并讨论了它们在伦理和实际方面的影响。首先,我们认为作者署名指导可能不适用于全球卫生研究,因为它要求作者撰写或大幅修改稿件。由于全球卫生领域大多数具有国际声誉的期刊都是用英文撰写的,这将系统性地、不公正地排除非英语研究人员,即使他们对研究项目做出了重大贡献。其次,当前关于作者署名顺序的指导并未解决或减轻全球卫生研究中因高收入国家与低收入和中等收入国家研究人员之间的权力差异而可能出现的不公平做法。它也没有充分认可诸如当地参与者招募等“技术任务”。第三,我们考虑医学科学期刊中存在的支持知名西方研究人员的真实或感知到的编辑偏见,以及助长错误署名和/或声望署名的风险。最后,我们探讨了关于作者署名的不同文化习俗和期望如何可能在低收入和中等收入国家与高收入国家的研究人员之间引发冲突,并导致不道德的作者署名行为。为有效应对这些问题,我们建议:1)针对全球卫生研究中的作者署名开展进一步的实证和概念研究;2)提高对全球卫生研究中作者署名问题的认识;3)制定反映全球卫生研究中作者署名相关考量的具体实践标准。
通过回顾生物伦理学和全球卫生文献,以及审视关于伦理作者署名的指导文件,我们确定了一组关于低收入和中等收入国家与高收入国家研究人员合作关系中作者署名的问题。我们提出了几项建议来解决这些问题。